1. Home
  2. ENVA vs ACAD Comparison

ENVA vs ACAD Comparison

Compare ENVA & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enova International Inc.

ENVA

Enova International Inc.

HOLD

Current Price

$144.47

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo ACADIA Pharmaceuticals Inc.

ACAD

ACADIA Pharmaceuticals Inc.

HOLD

Current Price

$21.69

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVA
ACAD
Founded
2011
1993
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.9B
IPO Year
2011
2000

Fundamental Metrics

Financial Performance
Metric
ENVA
ACAD
Price
$144.47
$21.69
Analyst Decision
Strong Buy
Buy
Analyst Count
5
22
Target Price
$173.00
$30.55
AVG Volume (30 Days)
158.9K
1.7M
Earning Date
04-23-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
55.05
69.12
EPS
11.52
2.30
Revenue
$3,151,653,000.00
$726,437,000.00
Revenue This Year
$149.98
$18.90
Revenue Next Year
$15.96
$11.62
P/E Ratio
$12.58
$9.81
Revenue Growth
18.58
40.45
52 Week Low
$88.11
$14.08
52 Week High
$176.68
$28.35

Technical Indicators

Market Signals
Indicator
ENVA
ACAD
Relative Strength Index (RSI) 57.35 46.16
Support Level $132.46 $21.51
Resistance Level $149.49 $22.03
Average True Range (ATR) 4.23 0.72
MACD 1.75 0.19
Stochastic Oscillator 76.22 51.38

Price Performance

Historical Comparison
ENVA
ACAD

About ENVA Enova International Inc.

Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-101, ACP-211, ACP-711, ACP-2591, etc.

Share on Social Networks: